Director, Division of Molecular Pathology & Cytogenetics
The University of California Irvine (UCI) School of Medicine, Department of Pathology & Laboratory Medicine, invites applications from MD or MD-PhD board-certified molecular pathologists to direct the Division of Molecular Pathology & Cytogenetics. The full-time academic appointment may be at the Assistant or Associate level in the Health Sciences Clinical or Clinical X series, depending on experience and extent of research effort. Clinical X appointments confer membership in the UCI Academic Senate.
As Director of Molecular Pathology & Cytogenetics, the successful recruit will have the administrative and interpersonal skills to effectively lead and coordinate clinical, teaching, and research activities within and beyond the division. Candidates should have extensive and current clinical expertise in Molecular Pathology. Directorship responsibilities will also include a newly-approved Cytogenetics/FISH Laboratory with separate faculty cytogeneticist; accordingly, experience and/or knowledge of cytogenetics lab operations is preferred. Clinical licensure and board certification in Molecular Pathology are required, as is dedication to teaching and mentoring, which will involve medical students, graduate students, residents, fellows, and junior faculty.
The successful recruit will also have the skills to carry out Molecular Pathology-related research as a thought leader or collaborative team member. Extramural research funding is welcome, but not required. Salary and rank will be commensurate with experience. To apply for this position, candidates should upload their curriculum vitae, statements (research, teaching, and diversity), reference information, and additional items to UCI Recruit: https://recruit.ap.uci.edu/apply/JPF05872.
UCI Medical Center is the primary clinical facility for UCI - recently ranked the #1 US university by Money Magazine and the #1 US university 'doing the most for the American Dream' by The New York Times - and home to the teaching and research programs of UCI Health. For 14 consecutive years, UCI Medical Center has been rated among the nation's best hospitals by US News & World Report and is home to the Chao Family Comprehensive Cancer Center (CFCCC), the only NCI-designated comprehensive cancer center in Orange County, the sixth most populous county in the US. CFCCC members come from more than 30 academic departments across 6 UCI schools, including Medicine, Biological Sciences, Physical Sciences, Information & Computer Science, Engineering, and Business. In early 2009, UCI Health opened Douglas Hospital, a state-of-the-art facility for clinical care, medical research, and training of future health care providers. Orange County offers year-round warm weather, cultural diversity, and proximity to the Pacific Ocean and many Southern California attractions.
The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC nondiscrimination policy. A recipient of an NSF ADVANCE award for gender equity, UCI is responsive to the needs of dual career couples, supports work-life balance through an array of family-friendly policies, and is dedicated to broadening participation in higher education.
Since 1965, the University of California, Irvine has combined the strengths of a major research university with the bounty of an incomparable Southern California location. UCI's unyielding commitment to rigorous academics, cutting-edge research, and leadership and character development makes the campus a driving force for innovation and discovery that serves our local, national and global communities.